High failure rates of melarsoprol for sleeping sickness, Democratic Republic of Congo
- PMID: 18507916
- PMCID: PMC2600279
- DOI: 10.3201/eid1406.071266
High failure rates of melarsoprol for sleeping sickness, Democratic Republic of Congo
Abstract
A retrospective chart review of 4,925 human African trypanosomiasis patients treated with melarsoprol in 2001-2003 in Equateur Nord Province of the Democratic Republic of Congo showed a treatment failure rate of 19.5%. This rate increased over the 3 years. Relapse rates were highest in the central part of the province.
References
-
- Legros D, Fournier C, Gastellu EM, Maiso F, Szumilin E. Therapeutic failure of melarsoprol among patients treated for late stage T.b. gambiense human African trypanosomiasis in Uganda. Bull Soc Pathol Exot. 1999;92:171–2. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources